DRUG DEVELOPMENT The Long Road to a New Medicine

Slides:



Advertisements
Similar presentations
The Drug Discovery Process
Advertisements

David M. Pollock Medical College of Georgia Discovery-Academia.
1 GL-1543a EDIT-long-road The Long Road to a New Medicine John H. (Wick) Johnson, Ph.D. Pfizer Global Research & Development Ann Arbor, Michigan.
Ferring Controlled Therapeutics
TBD-UK: The UK response in the discovery and development of new TB drugs. Dr Geoff Coxon Deputy Leader & Director of Medicinal Chemistry, TBD-UK APPG-TB.
1 Statistical Work Experiences in a Major Pharmaceutical Company Qiming Liao, Ph.D Hui Zhi, Ph.D GlaxoSmithKline Pharmaceuticals, R&D Nov 4, 2011.
Key Questions WHO WHAT WHERE WHEN WHY HOW Pfizer Inc
Alternative Careers in Pharma and Biotechnology Douglas Buckley Ph.D. May 13, 2011 Alternative Career Symposium Baylor College of Medicine.
Patrick Vallance Head of Drug Discovery GlaxoSmithKline
S TRUCTURAL B IOINFORMATICS. A subset of Bioinformatics concerned with the of biological structures - proteins, DNA, RNA, ligands etc. It is the first.
Genomics Commercialization Glen Schuler Managing Director, Industry Liaison Office University of Saskatchewan.
Nanotechnology in Drug Discovery- Development and Delivery
Health Economics & Policy 3 rd Edition James W. Henderson Chapter 13 Technology in Medicine.
Pharmaceutical Development and Review Process Rev. 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.
Introduction to the Manufacturing Science and Engineering section of AAPS and Careers in the Pharmaceutical and Biotech Industries SPEAKER NAME SPEAKER.
Stefan Franzén Introduction to clinical trials.
+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.
Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development.
Biomedical research methods. What are biomedical research methods? An integrated approach using chemical, mathematical and computer simulations, in vitro.
National University of Singapore Department of Pharmacy 21 Nov 2006 KPP Prasad, Ph.D. Quality Operations Director Pfizer Global Manufacturing The Pharmaceutical.
INVESTIGATIONAL DRUG SERVICES IN THE HOSPITAL Sheree Miller, Pharm.D. University of Washington Medical Center
ja.1 Careers for Statisticians and Statistical Programmers within the Pharmaceutical Industry Insert your name here.
Pharmacology II. The Business of Sick.
Stages of drug development
The Road Less Traveled: Alternative Career Paths in Veterinary Medicine Kathy Williams Center for Career Development.
I MPACT OF P HARMACOGENOMICS ON THE P HARMACEUTICAL I NDUSTRY Viktoriya Buchko American Institute of Chemical Engineers August 6, 2008.
Obtaining and Negotiatiing a Position in Industry/Biotech Roy G. Smith Ph.D. Director, Huffington Center on Aging Professor, Department of Molecular and.
Figure 4.1 NEW PRODUCT DEVELOPMENT PROCESS Finance Corporate strategy and portfolio decisions Regulatory affairs Marketing and sales + market research.
The Infectious Diseases Institute Kampala, Uganda InfoPoverty World Conference United Nations InfoPoverty World Conference United Nations Robert L. Mallett.
Dr Stewart Hay, CEO | | (03) www.therapeuticinnovation.com.au.
1 Value Assessment of Development-Stage Assets Pharmaceutical Products, Medical Devices, and Related Intellectual Property Frank S. Castellana, M.D., Eng.Sc.D.
Stefan Franzén Introduction to clinical trials.
DRUG DEVELOPMENT & REGULATIONS DR ARIF HASHMI. DRUG DEVELOPMENT Discovery and synthesis Preclinical development (chemical testing, biological testing,
Drugs Drugs & Medicine Emma Mackenzie December 19 th 2012 IB 12.
CS 790 – Bioinformatics Introduction and overview.
1 Intellectual Property in the Innovative Pharmaceutical Industry *** June 12, 2006 Gregg C. Benson Assistant General Counsel – Intellectual Property 1.
MEDICAL experts INDUSTRY Some of our clients. Pharmaceutical companies, manufacturers of medical and surgical devices, clinical research organizations,
Metals in Medicine Consortium Sydney Cancer Centre.
The New Drug Development Process (www. fda. gov/cder/handbook/develop
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
Privacy Symposium / HIPAA Summit
The pharmaceutical R&D process
Joint Conference of European Human Pharmacological Societies April 2013 ~ Nice Sophia Antipolis FRANCE Lessons learned from late phase failures and.
“Journey of a Drug” From Test Tube TO Prescribing Physician.
Collaboration in a Public Private Partnership in R & D for Public good Conference on Dispute Resolution in International Science and Technology Collaboration.
Clinical Trials - PHASE II. Introduction  Important part of drug discovery process  Why important??  Therapeutic exploratory trial  First time in.
httpwww.youtube.com/watch?v=DhxD6sVQEYc:// The Drug Discovery Process.
독성학 박 대 훈 한약재산업학과
The process of drug development. Drug development 0,8 – 1 mld. USD.
Clinical Trials.
Innovation and the Pharmaceutical Research and Development Industry January 2002 MSD South Africa.
29052-PorterJ32.ppt Roger J. Porter, M.D. Consultant Adjunct Professor of Pharmacology, USUHS Adjunct Professor of Neurology, Univ. of Pennsylvania Former.
Pharmacology Science that studies interactions of drugs with organism on different levels (subcellular, cellular, organ, systemic) Studies: - relationship.
Drug Development Process Stages involved in Regulating Drugs
Drug Discovery &Development
Prof. Dr. Basavaraj K. Nanjwade
Copyright © 2012 American Medical Association. All rights reserved.
A journey through drug discovery The life cycle of a new medicine
Biotechnology Objectives: At the end of this lecture we will be able to identify and describe the uses of biotechnology in society.
Ethics in clinical Trial
Innovation & the Pharmaceutical Research & Development Industry
Career Opportunities In Pharmacy. What is Pharmacy Pharmacy is the science and technique of preparing, researching, and distributing medicinal drugs.
Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases  Dhavalkumar D. Patel, MD, PhD, Christian Antoni,
Drug Design and Drug Discovery
10th Anniversary Celebration
Volume 21, Issue 9, Pages (September 2014)
Pharmaceuticals Industry
Project Management in the Pharmaceutical Industry
Global Nutraceuticals Market
Presentation transcript:

DRUG DEVELOPMENT The Long Road to a New Medicine SPEAKERS Dr. John H. “Wick” Johnson – Pfizer Global R&D Dr. David M. Pollock – Medical College of Georgia Dr. Terry J. Opgenorth – Abbott Laboratories Dr. Albert F. DeFelice – Food and Drug Administration Dr. James M. Norton – University of New England

DRUG DEVELOPMENT The Long Road to a New Medicine Objectives To acquaint you with the process of drug development To make you aware of job opportunities in the process-some of which may be new to you

The Long Road to a New Medicine Discovery Full Clinical Development Registration Extensive Safety Studies

The Long Road to a New Medicine Discovery-Academia - Dr. David Pollock Target Identification Synthesis of Compounds Screening 4

The Long Road to a New Medicine Synthesis of Compounds Discovery- Industry - Dr. Terry Opgenorth Efficacy Target Identification Synthesis of Compounds Screening 5

The Long Road to a New Medicine Pharmaceutical Formulation And Toxicology Extensive Safety Studies

Clinical and Regulatory-Dr. Al DeFelice The Long Road to a New Medicine Registration Clinical and Regulatory-Dr. Al DeFelice NDA/MAA Phase II 100-400 Patients Phase III 3-10,000 Patients Extensive Safety Studies Phase I Healthy Volunteers

Discussion – Dr. Jim Norton The Long Road to a New Medicine Discovery Full Clinical Development Registration Discussion – Dr. Jim Norton Extensive Safety Studies